FeesSafety
Pluang+

Cresud's land assets and IRSA operations support shareholder value amid mixed agricultural results

Market News
08 Aug 2026, 00:24 WIB
Seeking Alpha
View Source
Neutral
Cresud's land assets and IRSA operations support shareholder value amid mixed agricultural results

Cresud Sociedad Anónima remains primarily a holding company for IRSA with undervalued land assets, providing exposure to Argentine economic reforms and real estate. Recent reforms in Argentina brought partial liberalization, but key measures like export tariff cuts were smaller and slower than expected. IRSA’s operational improvements, including rising rental EBITDA, full office occupancy, and ongoing projects, have helped Cresud maintain real value distributions to shareholders. Agricultural operations showed mixed results with better yields and cattle profits offset by declining adjusted EBITDA, leaving the core agricultural business value largely unchanged in 2024.

More News

Deadlines set for lead plaintiff in class actions against Tigo Energy, Fluence Energy, and Anavex Life Sciences

Deadlines set for lead plaintiff in class actions against Tigo Energy, Fluence Energy, and Anavex Life Sciences

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against Tigo Energy, Fluence Energy, and Anavex Life Sciences. The lawsuits allege these companies made false or misleading stat...

Market News
Bearish
25 minutes ago
Heineken repurchases 9.5 million shares worth €679 million in latest buyback tranche

Heineken repurchases 9.5 million shares worth €679 million in latest buyback tranche

Heineken N.V. has repurchased a total of 9,510,681 shares under the second tranche of its €1.5 billion share buyback program, spending €679.2 million as of October 30, 2026. The company bought 159,700 shares on the exchange and 160,530 shares from He...

Company Fundamentals
Neutral
25 minutes ago
Alvotech to present at multiple investor conferences in November 2026.

Alvotech to present at multiple investor conferences in November 2026.

Alvotech, a global biotech company specializing in biosimilars, announced its management team will participate in several investor conferences in November 2026, including events in London, Oslo, and Stockholm. These presentations and fireside chats w...

Market News
Neutral
25 minutes ago
Alvotech to present at multiple investor conferences in November 2026

Alvotech to present at multiple investor conferences in November 2026

Alvotech, a global biotech company specializing in biosimilar medicines, announced its management team will participate in several investor conferences throughout November 2026. These include events in London, Oslo, and Stockholm, featuring presentat...

Market News
Neutral
25 minutes ago
Alvotech to present at four major investor conferences in November across Europe.

Alvotech to present at four major investor conferences in November across Europe.

Alvotech, a global biotechnology company specializing in biosimilar medicines, will participate in four international investor conferences in November held in the UK, Norway, and Sweden. These events include presentations and analyst discussions host...

Market News
Neutral
25 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App